Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK HPA (Health Protection Agency) injects new impetus into needle safety debate

This article was originally published in Clinica

Executive Summary

Needle safety has again been thrust under the spotlight in the UK, with the publication of a report into the incidence of injuries associated with infections from HIV and from hepatitis B and C. More needs to be done to reduce the number of needlesticks, says the Health Protection Agency (HPA), citing its findings. The agency also wants to ensure that injured workers undergo the appropriate tests, in a timely manner, in order to receive preventive treatment.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057783

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel